Oryzon Genomics to launch IPO before the end of 2015
Oryzon Genomics saldrá a Bolsa antes de que finalice 2015
Intel ID : 230835
| Synopsis |
|
Spain-based Oryzon Genomics will launch an IPO worth EUR 96.5m before the end of 2015, informed president and co-founder, Carlos Buesa, to Expansión on 27 October, 2015. The company plans to list all of its shares in the stock exchange; and, later, intends to carry out capital increases to raise funds to finance its growth and international expansion.
(content in spanish)
La empresa española Oryzon Genomics comenzará a cotizar en Bolsa antes de que finalice el año 2015, con una valoración de EUR 96,5m, según ha señalado su presidente y cofundador, Carlos Buesa, al diario Expansión el 27 de octubre de 2015. La compañía comenzaría a cotizar mediante listing (colocación directa en bolsa) de la totalidad de sus acciones, tras lo que prevé hacer ampliaciones de capital con las que captar fondos para financiar su crecimiento e internacionalización. |
| Intel ID | 230835 | |
| Value | EUR 96,50m (Approx.) | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Oryzon Genomics
(31 Dec 2022) |
Revenue: EUR 15,95m Net Debt: EUR 539,03m People: 44 |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Issuer
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Radar
| Date | Title | Type | Intel Grade | Country | Subsector | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
Mergers & Acquisitions
| Date | Target | Country | Buyer | Seller | VALUE (EURm) | Subsector | |||
|
|
|
|
|
- |
|
|
 |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.